| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Health Expenditures | 81 | 2023 | 2348 | 8.210 |
Why?
|
| Cost Sharing | 37 | 2021 | 407 | 6.990 |
Why?
|
| Medicare | 80 | 2023 | 6566 | 5.930 |
Why?
|
| Cost Savings | 33 | 2023 | 926 | 4.440 |
Why?
|
| Insurance, Health | 43 | 2021 | 2494 | 4.410 |
Why?
|
| Health Benefit Plans, Employee | 18 | 2021 | 332 | 4.140 |
Why?
|
| Blue Cross Blue Shield Insurance Plans | 15 | 2019 | 94 | 3.170 |
Why?
|
| Fee-for-Service Plans | 21 | 2022 | 694 | 3.020 |
Why?
|
| Reimbursement Mechanisms | 17 | 2022 | 670 | 2.670 |
Why?
|
| Managed Care Programs | 15 | 2018 | 950 | 2.650 |
Why?
|
| Medicare Part C | 9 | 2023 | 296 | 2.640 |
Why?
|
| Health Care Reform | 18 | 2018 | 1261 | 2.610 |
Why?
|
| Reimbursement, Incentive | 19 | 2022 | 540 | 2.580 |
Why?
|
| Economic Competition | 9 | 2023 | 214 | 2.280 |
Why?
|
| Quality of Health Care | 28 | 2023 | 4371 | 2.070 |
Why?
|
| Commerce | 15 | 2023 | 592 | 2.010 |
Why?
|
| United States | 171 | 2023 | 69872 | 2.010 |
Why?
|
| Cost Control | 22 | 2020 | 624 | 1.940 |
Why?
|
| Health Services | 9 | 2023 | 758 | 1.810 |
Why?
|
| Health Care Costs | 20 | 2021 | 3209 | 1.740 |
Why?
|
| Group Practice | 6 | 2021 | 149 | 1.630 |
Why?
|
| Deductibles and Coinsurance | 8 | 2019 | 316 | 1.590 |
Why?
|
| Delivery of Health Care | 23 | 2023 | 5319 | 1.560 |
Why?
|
| Budgets | 5 | 2018 | 229 | 1.550 |
Why?
|
| Patient Protection and Affordable Care Act | 16 | 2020 | 1209 | 1.490 |
Why?
|
| Health Care Sector | 3 | 2021 | 194 | 1.470 |
Why?
|
| Benchmarking | 8 | 2023 | 1042 | 1.340 |
Why?
|
| Health Maintenance Organizations | 10 | 2012 | 642 | 1.320 |
Why?
|
| Physicians | 14 | 2021 | 4567 | 1.300 |
Why?
|
| Financing, Personal | 7 | 2016 | 308 | 1.250 |
Why?
|
| Economics, Hospital | 4 | 2023 | 213 | 1.250 |
Why?
|
| Private Sector | 7 | 2020 | 392 | 1.200 |
Why?
|
| Medicaid | 11 | 2020 | 2736 | 1.190 |
Why?
|
| Models, Economic | 10 | 2022 | 713 | 1.150 |
Why?
|
| Physicians, Primary Care | 5 | 2021 | 591 | 1.100 |
Why?
|
| Prospective Payment System | 2 | 2021 | 133 | 1.070 |
Why?
|
| Health Facility Merger | 2 | 2023 | 53 | 1.000 |
Why?
|
| Personnel Turnover | 3 | 2020 | 83 | 0.980 |
Why?
|
| Health Facility Closure | 1 | 2023 | 18 | 0.910 |
Why?
|
| Medicare Part D | 6 | 2014 | 328 | 0.900 |
Why?
|
| Quality Assurance, Health Care | 6 | 2018 | 2212 | 0.850 |
Why?
|
| Hypoglycemic Agents | 5 | 2019 | 2872 | 0.820 |
Why?
|
| Insurance Coverage | 14 | 2019 | 1901 | 0.810 |
Why?
|
| Costs and Cost Analysis | 10 | 2021 | 1681 | 0.810 |
Why?
|
| Insurance Carriers | 5 | 2021 | 157 | 0.790 |
Why?
|
| Public Sector | 2 | 2014 | 265 | 0.760 |
Why?
|
| Medication Adherence | 8 | 2019 | 2063 | 0.750 |
Why?
|
| Quality Indicators, Health Care | 10 | 2019 | 1831 | 0.740 |
Why?
|
| Insurance, Health, Reimbursement | 3 | 2018 | 397 | 0.720 |
Why?
|
| Practice Management, Medical | 1 | 2021 | 196 | 0.700 |
Why?
|
| Patient Care | 4 | 2020 | 640 | 0.670 |
Why?
|
| Hospital Costs | 3 | 2021 | 985 | 0.660 |
Why?
|
| Insurance Benefits | 3 | 2009 | 183 | 0.650 |
Why?
|
| Efficiency, Organizational | 8 | 2017 | 695 | 0.640 |
Why?
|
| Health Services Research | 9 | 2016 | 1836 | 0.640 |
Why?
|
| Humans | 190 | 2023 | 744343 | 0.640 |
Why?
|
| Quality Improvement | 10 | 2019 | 3749 | 0.630 |
Why?
|
| Contract Services | 3 | 2013 | 94 | 0.600 |
Why?
|
| Hospitalization | 10 | 2023 | 10262 | 0.600 |
Why?
|
| Choice Behavior | 5 | 2015 | 803 | 0.580 |
Why?
|
| Insurance | 1 | 2018 | 111 | 0.570 |
Why?
|
| Hospitals | 7 | 2023 | 3952 | 0.570 |
Why?
|
| State Health Plans | 4 | 2018 | 216 | 0.560 |
Why?
|
| Contracts | 2 | 2015 | 60 | 0.560 |
Why?
|
| Massachusetts | 18 | 2019 | 8663 | 0.550 |
Why?
|
| Financing, Government | 5 | 2013 | 468 | 0.550 |
Why?
|
| Insurance Claim Review | 9 | 2020 | 720 | 0.540 |
Why?
|
| Drug Costs | 5 | 2016 | 1105 | 0.530 |
Why?
|
| Insurance, Medigap | 2 | 2013 | 19 | 0.530 |
Why?
|
| Chronic Disease | 9 | 2018 | 9146 | 0.500 |
Why?
|
| Health Policy | 8 | 2018 | 2661 | 0.500 |
Why?
|
| Physician Incentive Plans | 5 | 2018 | 161 | 0.490 |
Why?
|
| Anniversaries and Special Events | 1 | 2015 | 89 | 0.480 |
Why?
|
| Competitive Bidding | 1 | 2013 | 17 | 0.480 |
Why?
|
| Taxes | 4 | 2019 | 221 | 0.480 |
Why?
|
| Data Collection | 5 | 2018 | 3341 | 0.470 |
Why?
|
| Diabetes Mellitus | 9 | 2021 | 5751 | 0.460 |
Why?
|
| Aged | 58 | 2023 | 163280 | 0.440 |
Why?
|
| Salaries and Fringe Benefits | 2 | 2014 | 264 | 0.440 |
Why?
|
| Formularies as Topic | 1 | 2013 | 91 | 0.430 |
Why?
|
| Patient Preference | 2 | 2021 | 890 | 0.420 |
Why?
|
| Economic Recession | 1 | 2013 | 78 | 0.420 |
Why?
|
| Prescription Drugs | 4 | 2017 | 595 | 0.420 |
Why?
|
| Rate Setting and Review | 1 | 2011 | 41 | 0.420 |
Why?
|
| Competitive Behavior | 1 | 2012 | 74 | 0.410 |
Why?
|
| Economics | 1 | 2013 | 146 | 0.410 |
Why?
|
| Referral and Consultation | 4 | 2021 | 3528 | 0.390 |
Why?
|
| Fees, Medical | 1 | 2011 | 117 | 0.390 |
Why?
|
| Comparative Effectiveness Research | 2 | 2014 | 681 | 0.390 |
Why?
|
| Ambulatory Care | 5 | 2020 | 2708 | 0.390 |
Why?
|
| Medicare Part B | 1 | 2011 | 108 | 0.380 |
Why?
|
| Diagnosis-Related Groups | 2 | 2023 | 455 | 0.370 |
Why?
|
| Female | 85 | 2021 | 380194 | 0.370 |
Why?
|
| Male | 80 | 2022 | 350118 | 0.370 |
Why?
|
| Capitation Fee | 1 | 2010 | 116 | 0.370 |
Why?
|
| Insurance Pools | 2 | 2006 | 12 | 0.360 |
Why?
|
| Pharmaceutical Preparations | 2 | 2020 | 1071 | 0.360 |
Why?
|
| Income | 9 | 2017 | 1913 | 0.360 |
Why?
|
| Fees and Charges | 4 | 2015 | 195 | 0.350 |
Why?
|
| Program Evaluation | 6 | 2016 | 2488 | 0.340 |
Why?
|
| Periodicals as Topic | 2 | 2015 | 1432 | 0.340 |
Why?
|
| Hospitals, Rural | 2 | 2023 | 172 | 0.340 |
Why?
|
| Drug Prescriptions | 3 | 2019 | 1637 | 0.340 |
Why?
|
| Hospital-Physician Joint Ventures | 2 | 2020 | 30 | 0.320 |
Why?
|
| Social Welfare | 1 | 2009 | 87 | 0.310 |
Why?
|
| Disease Management | 4 | 2008 | 2459 | 0.310 |
Why?
|
| Specialization | 1 | 2013 | 777 | 0.310 |
Why?
|
| Primary Health Care | 7 | 2021 | 4558 | 0.310 |
Why?
|
| Geography | 1 | 2010 | 669 | 0.300 |
Why?
|
| Medical Savings Accounts | 1 | 2007 | 32 | 0.300 |
Why?
|
| Office Visits | 3 | 2018 | 598 | 0.290 |
Why?
|
| Fees, Pharmaceutical | 3 | 2014 | 64 | 0.290 |
Why?
|
| Patient Acceptance of Health Care | 7 | 2018 | 3022 | 0.290 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2019 | 11725 | 0.290 |
Why?
|
| Health Plan Implementation | 1 | 2010 | 352 | 0.280 |
Why?
|
| Home Care Services | 3 | 2009 | 606 | 0.280 |
Why?
|
| Patient-Centered Care | 1 | 2017 | 1439 | 0.280 |
Why?
|
| Episode of Care | 4 | 2022 | 126 | 0.280 |
Why?
|
| Decision Making, Organizational | 2 | 2004 | 139 | 0.280 |
Why?
|
| Middle Aged | 45 | 2021 | 213383 | 0.270 |
Why?
|
| Cost Allocation | 2 | 2021 | 51 | 0.270 |
Why?
|
| Morals | 1 | 2009 | 284 | 0.270 |
Why?
|
| Nursing Homes | 4 | 2014 | 1036 | 0.270 |
Why?
|
| Adult | 43 | 2023 | 214055 | 0.260 |
Why?
|
| Politics | 3 | 2018 | 791 | 0.260 |
Why?
|
| Uncompensated Care | 1 | 2005 | 34 | 0.260 |
Why?
|
| Evidence-Based Practice | 1 | 2010 | 500 | 0.260 |
Why?
|
| Risk Sharing, Financial | 1 | 2005 | 47 | 0.260 |
Why?
|
| Health Services Misuse | 3 | 2016 | 243 | 0.250 |
Why?
|
| Risk Adjustment | 4 | 2019 | 594 | 0.250 |
Why?
|
| Drugs, Generic | 3 | 2019 | 421 | 0.240 |
Why?
|
| Motivation | 3 | 2021 | 1971 | 0.240 |
Why?
|
| Cross-Sectional Studies | 12 | 2023 | 25043 | 0.230 |
Why?
|
| Actuarial Analysis | 1 | 2003 | 378 | 0.230 |
Why?
|
| Adolescent | 26 | 2021 | 85781 | 0.230 |
Why?
|
| Young Adult | 20 | 2021 | 56430 | 0.220 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2019 | 3255 | 0.210 |
Why?
|
| Privatization | 1 | 2022 | 41 | 0.210 |
Why?
|
| Pandemics | 2 | 2022 | 8388 | 0.210 |
Why?
|
| Cost-Benefit Analysis | 11 | 2016 | 5391 | 0.210 |
Why?
|
| Life Expectancy | 2 | 2020 | 1184 | 0.200 |
Why?
|
| Homes for the Aged | 2 | 2014 | 260 | 0.200 |
Why?
|
| Health Status Disparities | 2 | 2016 | 1797 | 0.200 |
Why?
|
| Matched-Pair Analysis | 2 | 2019 | 288 | 0.200 |
Why?
|
| Hospitals, Private | 1 | 2021 | 63 | 0.200 |
Why?
|
| Insurance Selection Bias | 2 | 2018 | 67 | 0.190 |
Why?
|
| Organizational Case Studies | 2 | 2012 | 299 | 0.190 |
Why?
|
| Health Status | 3 | 2016 | 4034 | 0.190 |
Why?
|
| Confidence Intervals | 2 | 2021 | 2971 | 0.190 |
Why?
|
| Health Care Surveys | 8 | 2020 | 2453 | 0.190 |
Why?
|
| California | 6 | 2019 | 1402 | 0.190 |
Why?
|
| Disclosure | 2 | 2017 | 736 | 0.180 |
Why?
|
| Patient Compliance | 2 | 2008 | 2684 | 0.180 |
Why?
|
| Preferred Provider Organizations | 2 | 2013 | 38 | 0.180 |
Why?
|
| Anticholesteremic Agents | 1 | 2008 | 979 | 0.180 |
Why?
|
| Retirement | 1 | 2021 | 215 | 0.180 |
Why?
|
| Negotiating | 2 | 2021 | 133 | 0.180 |
Why?
|
| Cardiology Service, Hospital | 2 | 2015 | 246 | 0.170 |
Why?
|
| Health Services for the Aged | 4 | 2021 | 269 | 0.170 |
Why?
|
| Quality Control | 3 | 2015 | 841 | 0.170 |
Why?
|
| Health Services Accessibility | 5 | 2020 | 5137 | 0.170 |
Why?
|
| Hospital Administration | 1 | 2023 | 353 | 0.170 |
Why?
|
| Policy Making | 2 | 2013 | 554 | 0.170 |
Why?
|
| Forecasting | 4 | 2015 | 2951 | 0.170 |
Why?
|
| Insurance, Pharmaceutical Services | 2 | 2014 | 336 | 0.170 |
Why?
|
| Sex Factors | 5 | 2021 | 10397 | 0.160 |
Why?
|
| Managed Competition | 2 | 2016 | 34 | 0.160 |
Why?
|
| Attitude to Health | 2 | 2005 | 2052 | 0.150 |
Why?
|
| Disabled Persons | 2 | 2005 | 1212 | 0.150 |
Why?
|
| Financial Management, Hospital | 1 | 2018 | 74 | 0.150 |
Why?
|
| Ownership | 1 | 2020 | 332 | 0.150 |
Why?
|
| Provider-Sponsored Organizations | 1 | 2016 | 13 | 0.150 |
Why?
|
| Child Health Services | 3 | 2013 | 667 | 0.150 |
Why?
|
| Oregon | 1 | 2017 | 140 | 0.150 |
Why?
|
| Medical Oncology | 2 | 2019 | 2265 | 0.140 |
Why?
|
| Linear Models | 8 | 2021 | 5952 | 0.140 |
Why?
|
| Socioeconomic Factors | 5 | 2019 | 7785 | 0.140 |
Why?
|
| Models, Theoretical | 1 | 2009 | 3589 | 0.140 |
Why?
|
| Washington | 1 | 2017 | 313 | 0.140 |
Why?
|
| Aged, 80 and over | 19 | 2019 | 57776 | 0.140 |
Why?
|
| Perinatal Care | 1 | 2018 | 227 | 0.140 |
Why?
|
| Government Regulation | 1 | 2020 | 522 | 0.140 |
Why?
|
| Empirical Research | 2 | 2013 | 120 | 0.130 |
Why?
|
| Organizational Innovation | 2 | 2011 | 559 | 0.130 |
Why?
|
| Databases, Factual | 4 | 2019 | 7729 | 0.130 |
Why?
|
| Legislation, Drug | 1 | 2017 | 206 | 0.130 |
Why?
|
| Medically Uninsured | 4 | 2019 | 853 | 0.130 |
Why?
|
| Tobacco Use Cessation | 1 | 2016 | 95 | 0.130 |
Why?
|
| Fee Schedules | 2 | 2013 | 86 | 0.120 |
Why?
|
| Age Factors | 5 | 2021 | 18370 | 0.120 |
Why?
|
| Subacute Care | 1 | 2017 | 168 | 0.120 |
Why?
|
| Patient Readmission | 3 | 2023 | 3114 | 0.120 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2015 | 153 | 0.120 |
Why?
|
| Antidepressive Agents | 2 | 2018 | 2838 | 0.120 |
Why?
|
| Access to Information | 1 | 2017 | 320 | 0.120 |
Why?
|
| Eligibility Determination | 3 | 2013 | 403 | 0.120 |
Why?
|
| Coronary Artery Bypass | 2 | 2007 | 2289 | 0.120 |
Why?
|
| Hospital Charges | 1 | 2015 | 362 | 0.120 |
Why?
|
| Employee Incentive Plans | 1 | 2013 | 15 | 0.110 |
Why?
|
| Cohort Studies | 8 | 2021 | 40561 | 0.110 |
Why?
|
| Health Care Rationing | 2 | 2010 | 437 | 0.110 |
Why?
|
| Patient Satisfaction | 2 | 2016 | 3396 | 0.110 |
Why?
|
| Organizational Policy | 2 | 2021 | 429 | 0.110 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2014 | 238 | 0.110 |
Why?
|
| Metformin | 2 | 2018 | 835 | 0.110 |
Why?
|
| Rural Population | 1 | 2023 | 2210 | 0.110 |
Why?
|
| Emergency Service, Hospital | 3 | 2017 | 7659 | 0.110 |
Why?
|
| Gross Domestic Product | 1 | 2012 | 77 | 0.100 |
Why?
|
| Residence Characteristics | 4 | 2018 | 2050 | 0.100 |
Why?
|
| Patient Participation | 1 | 2021 | 1457 | 0.100 |
Why?
|
| Mammography | 3 | 2016 | 2476 | 0.100 |
Why?
|
| Social Values | 1 | 2012 | 224 | 0.100 |
Why?
|
| Regression Analysis | 4 | 2011 | 6459 | 0.100 |
Why?
|
| Drug Therapy | 1 | 2014 | 497 | 0.100 |
Why?
|
| Contraceptive Agents, Female | 1 | 2013 | 135 | 0.100 |
Why?
|
| Preventive Medicine | 1 | 2013 | 264 | 0.100 |
Why?
|
| Neoplasms | 5 | 2021 | 21683 | 0.100 |
Why?
|
| Drug Resistance, Microbial | 1 | 2014 | 862 | 0.090 |
Why?
|
| Models, Econometric | 4 | 2005 | 218 | 0.090 |
Why?
|
| Relative Value Scales | 1 | 2010 | 84 | 0.090 |
Why?
|
| Hospital-Physician Relations | 1 | 2010 | 18 | 0.090 |
Why?
|
| Physician-Patient Relations | 1 | 2004 | 3229 | 0.090 |
Why?
|
| Utilization Review | 2 | 2013 | 392 | 0.090 |
Why?
|
| Federal Government | 2 | 2012 | 260 | 0.090 |
Why?
|
| Kidney Failure, Chronic | 2 | 2018 | 2538 | 0.090 |
Why?
|
| Drug Therapy, Combination | 2 | 2018 | 6489 | 0.090 |
Why?
|
| Medical Assistance | 1 | 2010 | 104 | 0.090 |
Why?
|
| Retrospective Studies | 9 | 2019 | 77449 | 0.090 |
Why?
|
| Contraception | 1 | 2013 | 359 | 0.090 |
Why?
|
| Arkansas | 2 | 2019 | 52 | 0.090 |
Why?
|
| Early Detection of Cancer | 3 | 2022 | 3086 | 0.080 |
Why?
|
| Patients | 1 | 2016 | 900 | 0.080 |
Why?
|
| Reference Values | 1 | 2016 | 4982 | 0.080 |
Why?
|
| Propensity Score | 2 | 2013 | 1781 | 0.080 |
Why?
|
| State Government | 1 | 2011 | 372 | 0.080 |
Why?
|
| Preventive Health Services | 1 | 2013 | 575 | 0.080 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2012 | 841 | 0.080 |
Why?
|
| Terminal Care | 2 | 2018 | 1694 | 0.080 |
Why?
|
| Risk Management | 2 | 2017 | 571 | 0.080 |
Why?
|
| Radiation Oncology | 1 | 2014 | 555 | 0.080 |
Why?
|
| Demography | 1 | 2013 | 1656 | 0.080 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2014 | 806 | 0.080 |
Why?
|
| Maryland | 2 | 2018 | 276 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 8642 | 0.070 |
Why?
|
| Cardiac Care Facilities | 1 | 2007 | 35 | 0.070 |
Why?
|
| Alcoholism | 1 | 2018 | 1906 | 0.070 |
Why?
|
| Models, Statistical | 5 | 2018 | 5102 | 0.070 |
Why?
|
| Models, Organizational | 1 | 2010 | 574 | 0.070 |
Why?
|
| National Health Insurance, United States | 1 | 2007 | 104 | 0.070 |
Why?
|
| Annual Reports as Topic | 2 | 2016 | 33 | 0.070 |
Why?
|
| Databases as Topic | 1 | 2008 | 475 | 0.070 |
Why?
|
| Inpatients | 1 | 2018 | 2518 | 0.070 |
Why?
|
| Planning Techniques | 1 | 2006 | 82 | 0.070 |
Why?
|
| Information Systems | 1 | 2008 | 410 | 0.070 |
Why?
|
| Drug Discovery | 1 | 2014 | 1058 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 10943 | 0.070 |
Why?
|
| Hypercholesterolemia | 1 | 2012 | 1151 | 0.070 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 12245 | 0.070 |
Why?
|
| Organizational Culture | 2 | 2010 | 510 | 0.060 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2013 | 941 | 0.060 |
Why?
|
| Case Management | 2 | 2003 | 286 | 0.060 |
Why?
|
| Electrocardiography | 1 | 2018 | 6442 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2019 | 3336 | 0.060 |
Why?
|
| Population Dynamics | 1 | 2006 | 302 | 0.060 |
Why?
|
| Family Characteristics | 2 | 2006 | 1000 | 0.060 |
Why?
|
| Mental Health Services | 1 | 2015 | 1643 | 0.060 |
Why?
|
| Patient Discharge | 1 | 2017 | 3313 | 0.060 |
Why?
|
| Heart Failure | 1 | 2008 | 10900 | 0.060 |
Why?
|
| Caregivers | 2 | 2009 | 2094 | 0.060 |
Why?
|
| Decision Trees | 2 | 2005 | 506 | 0.060 |
Why?
|
| Cardiology | 1 | 2015 | 1668 | 0.060 |
Why?
|
| Frail Elderly | 2 | 2013 | 693 | 0.060 |
Why?
|
| Comorbidity | 3 | 2019 | 10388 | 0.060 |
Why?
|
| SEER Program | 2 | 2021 | 1508 | 0.060 |
Why?
|
| Medicare Assignment | 2 | 2013 | 9 | 0.060 |
Why?
|
| Organizational Objectives | 1 | 2006 | 438 | 0.060 |
Why?
|
| Inflation, Economic | 1 | 2003 | 28 | 0.060 |
Why?
|
| Time Factors | 3 | 2021 | 40075 | 0.060 |
Why?
|
| Michigan | 4 | 2007 | 350 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2016 | 6196 | 0.060 |
Why?
|
| Time and Motion Studies | 1 | 2003 | 149 | 0.060 |
Why?
|
| Opioid-Related Disorders | 1 | 2018 | 2065 | 0.050 |
Why?
|
| Product Line Management | 1 | 2002 | 2 | 0.050 |
Why?
|
| Myocardial Revascularization | 1 | 2007 | 841 | 0.050 |
Why?
|
| Drug Approval | 2 | 2014 | 742 | 0.050 |
Why?
|
| Program Development | 2 | 2007 | 1316 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 3674 | 0.050 |
Why?
|
| Hospice Care | 1 | 2010 | 672 | 0.050 |
Why?
|
| Insurance, Hospitalization | 1 | 2002 | 30 | 0.050 |
Why?
|
| Receptor, erbB-2 | 1 | 2012 | 2416 | 0.050 |
Why?
|
| Logistic Models | 3 | 2018 | 13408 | 0.050 |
Why?
|
| Stomach Ulcer | 1 | 2002 | 125 | 0.050 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2005 | 1683 | 0.050 |
Why?
|
| Neuraminidase | 1 | 2002 | 210 | 0.050 |
Why?
|
| Lipid Regulating Agents | 1 | 2021 | 24 | 0.050 |
Why?
|
| Decision Making | 2 | 2007 | 3887 | 0.050 |
Why?
|
| Positive-Pressure Respiration | 1 | 2005 | 633 | 0.050 |
Why?
|
| Health Behavior | 1 | 2013 | 2636 | 0.050 |
Why?
|
| Marketing of Health Services | 1 | 2002 | 153 | 0.050 |
Why?
|
| Antipsychotic Agents | 1 | 2014 | 3057 | 0.050 |
Why?
|
| Government Programs | 1 | 2023 | 275 | 0.050 |
Why?
|
| Health Promotion | 1 | 2013 | 2205 | 0.050 |
Why?
|
| Age Distribution | 1 | 2006 | 2902 | 0.050 |
Why?
|
| Information Services | 1 | 2002 | 244 | 0.050 |
Why?
|
| Pediatrics | 1 | 2015 | 3475 | 0.050 |
Why?
|
| Depressive Disorder, Major | 1 | 2018 | 4644 | 0.050 |
Why?
|
| Substance-Related Disorders | 1 | 2016 | 4258 | 0.040 |
Why?
|
| Critical Care | 1 | 2013 | 2647 | 0.040 |
Why?
|
| Reminder Systems | 1 | 2003 | 371 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2022 | 11124 | 0.040 |
Why?
|
| Treatment Refusal | 1 | 2003 | 421 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2015 | 4687 | 0.040 |
Why?
|
| Infant, Newborn | 4 | 2016 | 25625 | 0.040 |
Why?
|
| Long-Term Care | 1 | 2003 | 607 | 0.040 |
Why?
|
| Cardiovascular Diseases | 3 | 2021 | 15165 | 0.040 |
Why?
|
| Disability Evaluation | 2 | 2017 | 1827 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2012 | 13989 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2011 | 3843 | 0.040 |
Why?
|
| Infant | 4 | 2016 | 35136 | 0.040 |
Why?
|
| Mass Screening | 2 | 2022 | 5255 | 0.040 |
Why?
|
| Respiratory Insufficiency | 1 | 2005 | 1199 | 0.040 |
Why?
|
| Cholesterol, LDL | 2 | 2019 | 2356 | 0.040 |
Why?
|
| Social Class | 1 | 2006 | 1999 | 0.040 |
Why?
|
| Child, Preschool | 4 | 2016 | 41006 | 0.040 |
Why?
|
| Employment | 1 | 2003 | 1132 | 0.040 |
Why?
|
| Insurance Claim Reporting | 1 | 2017 | 163 | 0.040 |
Why?
|
| Length of Stay | 1 | 2010 | 6309 | 0.030 |
Why?
|
| Cost of Illness | 2 | 2004 | 1859 | 0.030 |
Why?
|
| Censuses | 1 | 2017 | 200 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 9959 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 7181 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2013 | 21746 | 0.030 |
Why?
|
| Decision Support Techniques | 2 | 2002 | 1956 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2002 | 1359 | 0.030 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2005 | 1414 | 0.030 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2016 | 214 | 0.030 |
Why?
|
| Workload | 1 | 2020 | 850 | 0.030 |
Why?
|
| Diabetic Retinopathy | 1 | 2003 | 1210 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2003 | 1786 | 0.030 |
Why?
|
| Antitrust Laws | 1 | 2013 | 7 | 0.030 |
Why?
|
| Breast Neoplasms | 3 | 2016 | 20822 | 0.030 |
Why?
|
| Bankruptcy | 1 | 2013 | 27 | 0.030 |
Why?
|
| Child | 5 | 2016 | 77709 | 0.030 |
Why?
|
| Missouri | 1 | 2013 | 117 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13695 | 0.030 |
Why?
|
| Skilled Nursing Facilities | 1 | 2017 | 372 | 0.030 |
Why?
|
| Physician Self-Referral | 1 | 2012 | 18 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 1 | 2022 | 2494 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 2429 | 0.030 |
Why?
|
| Delusions | 1 | 2014 | 300 | 0.030 |
Why?
|
| Hallucinations | 1 | 2014 | 360 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2002 | 2282 | 0.030 |
Why?
|
| Inappropriate Prescribing | 1 | 2014 | 202 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 3798 | 0.020 |
Why?
|
| Influenza, Human | 1 | 2002 | 1479 | 0.020 |
Why?
|
| Critical Pathways | 1 | 2014 | 476 | 0.020 |
Why?
|
| Markov Chains | 2 | 2005 | 969 | 0.020 |
Why?
|
| Tobacco Use Disorder | 1 | 2016 | 688 | 0.020 |
Why?
|
| Information Storage and Retrieval | 1 | 2015 | 824 | 0.020 |
Why?
|
| Cause of Death | 1 | 2020 | 3584 | 0.020 |
Why?
|
| Ambulatory Care Facilities | 1 | 2016 | 933 | 0.020 |
Why?
|
| Aggression | 1 | 2014 | 753 | 0.020 |
Why?
|
| Research Support as Topic | 1 | 2014 | 705 | 0.020 |
Why?
|
| National Health Programs | 1 | 2013 | 445 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 1375 | 0.020 |
Why?
|
| Outpatients | 1 | 2016 | 1486 | 0.020 |
Why?
|
| Counseling | 1 | 2016 | 1523 | 0.020 |
Why?
|
| Health Literacy | 1 | 2013 | 414 | 0.020 |
Why?
|
| Algorithms | 2 | 2021 | 13881 | 0.020 |
Why?
|
| Glyburide | 1 | 2008 | 113 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2013 | 969 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2015 | 2682 | 0.020 |
Why?
|
| Confidentiality | 1 | 2010 | 612 | 0.020 |
Why?
|
| Health Education | 1 | 2013 | 1056 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 2 | 2014 | 7279 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2014 | 1099 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2012 | 1660 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2013 | 1049 | 0.020 |
Why?
|
| New York | 1 | 2008 | 886 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2018 | 9849 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2010 | 789 | 0.020 |
Why?
|
| Women's Health Services | 1 | 2005 | 93 | 0.020 |
Why?
|
| Risk Factors | 4 | 2019 | 72290 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2014 | 6038 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2014 | 2266 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2020 | 4468 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2010 | 2373 | 0.010 |
Why?
|
| Social Marketing | 1 | 2003 | 52 | 0.010 |
Why?
|
| Women's Health | 1 | 2013 | 2034 | 0.010 |
Why?
|
| Hospitals, General | 1 | 2007 | 749 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2008 | 1959 | 0.010 |
Why?
|
| Immunization Programs | 1 | 2005 | 260 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2013 | 2148 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 6993 | 0.010 |
Why?
|
| Critical Illness | 1 | 2013 | 2670 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2014 | 4043 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2013 | 2788 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 4933 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2012 | 10252 | 0.010 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2003 | 501 | 0.010 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2007 | 1873 | 0.010 |
Why?
|
| Smoking | 1 | 2016 | 8987 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 14722 | 0.010 |
Why?
|
| Health Services Needs and Demand | 1 | 2007 | 1411 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2014 | 3309 | 0.010 |
Why?
|
| Drug Industry | 1 | 2003 | 746 | 0.010 |
Why?
|
| Pregnancy | 1 | 2018 | 29144 | 0.010 |
Why?
|
| Quality of Life | 2 | 2010 | 12804 | 0.010 |
Why?
|
| Geriatric Assessment | 1 | 2003 | 1372 | 0.010 |
Why?
|
| United States Food and Drug Administration | 1 | 2003 | 1584 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2005 | 2716 | 0.010 |
Why?
|
| Depression | 1 | 2014 | 7766 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2014 | 6487 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2005 | 3610 | 0.010 |
Why?
|
| Health Surveys | 1 | 2002 | 4037 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2003 | 23338 | 0.010 |
Why?
|
| Risk | 1 | 2003 | 9687 | 0.010 |
Why?
|
| Hypertension | 1 | 2010 | 8480 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 7913 | 0.010 |
Why?
|
| Insulin | 1 | 2002 | 6580 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 12959 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 39050 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 15076 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2002 | 63114 | 0.000 |
Why?
|